139 related articles for article (PubMed ID: 33586962)
21. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis.
Zhang M; Li G; Zhang Y; Kang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():78-83. PubMed ID: 29031112
[TBL] [Abstract][Full Text] [Related]
22. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Lin P; Sinha U; Betz A
Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
[TBL] [Abstract][Full Text] [Related]
23. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
[No Abstract] [Full Text] [Related]
24. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
[TBL] [Abstract][Full Text] [Related]
25. Affinity capillary electrophoresis for the determination of binding affinities for low molecular weight heparins and antithrombin-III.
Dinges MM; Solakyildirim K; Larive CK
Electrophoresis; 2014 May; 35(10):1469-77. PubMed ID: 24616065
[TBL] [Abstract][Full Text] [Related]
26. Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin.
Brieger D; Dawes J
Thromb Haemost; 1996 May; 75(5):740-6. PubMed ID: 8725716
[TBL] [Abstract][Full Text] [Related]
27. Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.
Guerrini M; Elli S; Gaudesi D; Torri G; Casu B; Mourier P; Herman F; Boudier C; Lorenz M; Viskov C
J Med Chem; 2010 Nov; 53(22):8030-40. PubMed ID: 21028827
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.
Condac E; Strachan H; Gutierrez-Sanchez G; Brainard B; Giese C; Heiss C; Johnson D; Azadi P; Bergmann C; Orlando R; Esmon CT; Harenberg J; Moremen K; Wang L
Glycobiology; 2012 Sep; 22(9):1183-92. PubMed ID: 22641771
[TBL] [Abstract][Full Text] [Related]
30. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation.
Maruyama T; Toida T; Imanari T; Yu G; Linhardt RJ
Carbohydr Res; 1998 Jan; 306(1-2):35-43. PubMed ID: 9691438
[TBL] [Abstract][Full Text] [Related]
31. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
[TBL] [Abstract][Full Text] [Related]
33. Structure of the antithrombin-binding site in heparin.
Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
[TBL] [Abstract][Full Text] [Related]
34. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
35. Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran.
Ammollo CT; Semeraro N; Carratù MR; Colucci M; Semeraro F
J Pharmacol Exp Ther; 2016 Feb; 356(2):305-13. PubMed ID: 26578266
[TBL] [Abstract][Full Text] [Related]
36. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
[TBL] [Abstract][Full Text] [Related]
37. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
38. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
[TBL] [Abstract][Full Text] [Related]
39. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
Peyrou V; Béguin S; Boneu B; Hemker HC
Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
[TBL] [Abstract][Full Text] [Related]
40. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]